These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3785489)

  • 21. Possible applications of polyunsaturated fatty acids in cancer therapy.
    Spector AA; North JA; Cornelius AS; Buettner GR
    World Rev Nutr Diet; 1994; 76():81-5. PubMed ID: 7856242
    [No Abstract]   [Full Text] [Related]  

  • 22. The impact of polyunsaturated fatty acids in reducing child attention deficit and hyperactivity disorders.
    Transler C; Eilander A; Mitchell S; van de Meer N
    J Atten Disord; 2010 Nov; 14(3):232-46. PubMed ID: 20424008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-3 polyunsaturated fatty acids and statins in heart failure.
    Smith GD; Brion MJ; Sterne JA
    Lancet; 2009 Jan; 373(9661):378; author reply 380-1. PubMed ID: 19186265
    [No Abstract]   [Full Text] [Related]  

  • 24. [Prostaglandin E1: results and perspectives in clinical practice].
    Guseva NG
    Klin Med (Mosk); 2001; 79(2):4-10. PubMed ID: 11419084
    [No Abstract]   [Full Text] [Related]  

  • 25. Polyunsaturated fatty acids in multiple sclerosis.
    Bates D; Fawcett PR; Shaw DA; Weightman D
    Br Med J; 1979 Mar; 1(6164):683. PubMed ID: 435724
    [No Abstract]   [Full Text] [Related]  

  • 26. Polyunsaturated fatty acids and colchicine in multiple sclerosis.
    Horrobin DF; Botez T; Botez MI
    Br Med J; 1979 Jan; 1(6157):199-200. PubMed ID: 421025
    [No Abstract]   [Full Text] [Related]  

  • 27. Trial of polyunsaturated fatty acids in non-relapsing multiple sclerosis.
    Bates D; Fawcett PR; Shaw DA; Weightman D
    Br Med J; 1977 Oct; 2(6092):932-3. PubMed ID: 334337
    [No Abstract]   [Full Text] [Related]  

  • 28. Polyunsaturated fatty acid supplementation for ADHD symptoms: response to commentary.
    Sinn N
    J Dev Behav Pediatr; 2007 Jun; 28(3):262-3. PubMed ID: 17565297
    [No Abstract]   [Full Text] [Related]  

  • 29. Omega-3 polyunsaturated fatty acids (Omacor) for hypertriglyceridemia.
    Med Lett Drugs Ther; 2005 Nov; 47(1221):91. PubMed ID: 16267495
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of alprostadil on blood rheology and nucleoside metabolism in patients affected with lower limb chronic ischaemia.
    Acciavatti A; Laghi Pasini F; Capecchi PL; Messa GL; Lazzerini PE; De Giorgi L; Acampa M; Di Perri T
    Clin Hemorheol Microcirc; 2001; 24(1):49-57. PubMed ID: 11345234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect, on renal function, of a product rich in polyunsaturated fatty acids: results obtained in subjects with chronic renal failure caused by nephroangiosclerosis].
    Bernardi P; Bastagli L; Pecoraro F; Vitolo A; Minelli C; Cavazza M; Adani C
    Boll Soc Ital Biol Sper; 1982 Jan; 58(1-2):50-4. PubMed ID: 6802153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of sudden cardiac death by n-3 polyunsaturated fatty acids.
    Leaf A
    Fundam Clin Pharmacol; 2006 Dec; 20(6):525-38. PubMed ID: 17109646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polyunsaturated fatty acids and epilepsy.
    Taha AY; Burnham WM; Auvin S
    Epilepsia; 2010 Aug; 51(8):1348-58. PubMed ID: 20608961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Molecular mechanisms of action and health benefits of polyunsaturated fatty acids].
    Rodríguez-Cruz M; Tovar AR; del Prado M; Torres N
    Rev Invest Clin; 2005; 57(3):457-72. PubMed ID: 16187707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Experience in using polyunsaturated fatty acids in the combined sanatorium and health resort treatment of patients with stage-I ischemic heart disease].
    Aznaur'ian MS; Bykov OD; Buldakov AA; Sevast'ianov AV
    Vopr Pitan; 1985; (1):74-5. PubMed ID: 3984296
    [No Abstract]   [Full Text] [Related]  

  • 36. Hypertension prevention: from nutrients to (fortified) foods to dietary patterns. Focus on fatty acids.
    Grynberg A
    J Hum Hypertens; 2005 Dec; 19 Suppl 3():S25-33. PubMed ID: 16302007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-3 polyunsaturated fatty acids and statins in heart failure.
    Gibson LM
    Lancet; 2009 Jan; 373(9661):378; author reply 380-1. PubMed ID: 19186264
    [No Abstract]   [Full Text] [Related]  

  • 38. [Diminution of the toxicity of a stable free radical by unsaturated fatty acids in mice].
    Deby C; Benmiloud M; Deby-Dupont G
    C R Seances Soc Biol Fil; 1973; 167(11):1700-3. PubMed ID: 4803149
    [No Abstract]   [Full Text] [Related]  

  • 39. Cancer mortality and polyunsaturated fatty acids.
    Singman HS; Archer M; Bergner L
    Mt Sinai J Med; 1973; 40(5):677-80. PubMed ID: 4542421
    [No Abstract]   [Full Text] [Related]  

  • 40. Polyunsaturated fatty acids for prevention of atrial fibrillation: a 'fishy' story.
    Savelieva I; Camm AJ
    Europace; 2011 Feb; 13(2):149-52. PubMed ID: 21252194
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.